Randomized trial · people
NAD+ rose with nicotinamide riboside in a 6-week crossover trial
Checked against the paper Randomized trialPublished by PepVault
The takeaway
This trial shows that ongoing use of an NAD+ precursor raised NAD+ metabolism in healthy middle-aged and older adults and was well tolerated for 6 weeks. Any heart or blood vessel benefit is still unproven.
- Kind
- Randomized trial
- Studied in
- People
- Published
- 2018
- Journal
- Nat Commun
What they tested
The team tested whether ongoing supplementation with nicotinamide riboside (NR), a vitamin the body uses to make NAD+, is well tolerated and raises NAD+ in healthy middle-aged and older people.
How the study was done
A randomized, double-blind, placebo-controlled crossover trial in healthy middle-aged and older adults. Each person had 6 weeks of NR and 6 weeks of placebo (an inactive look-alike), in random order, without knowing which was which.

What they found
People tolerated NR well across the 6-week supplementation period. NR boosted NAD+ metabolism. The researchers also took an early look at body function, and they singled out blood pressure and arterial stiffness (how rigid the artery walls are) as areas for future trials to study further.
What it doesn’t show
Each treatment period lasted only 6 weeks, and everyone was healthy, so the trial does not show long-term effects or effects in people with disease. The blood pressure and arterial stiffness results were only a first look, and this trial does not show that NR lowers either.
The paper
Martens et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018.
The compound
More studies on NAD+
- NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 daysRandomized trial · people · 2026
- NMN raised serum nicotinamide over 12 weeks in middle-aged adultsRandomized trial · people · 2023
- NMN supplements raised blood NAD+ levels in healthy older menRandomized trial · people · 2022
- NMN raised muscle insulin sensitivity in women with prediabetesRandomized trial · people · 2021
- Every study on NAD+
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.